{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"153-003-862-996-449","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"153-003-862-996-449","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8903,"type":"PATENT","title":"Johns Hopkins Univ Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":17938,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8218,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search applicants and owners= \"Johns Hopkins Univ\", \"Univ Johns Hopkins\"
Select more for logical variants
Add to collection
Total patents: 12941
Search applicants and owners= \"Johns Hopkins Univ\", \"Univ Johns Hopkins\"
Select more for logical variants
Add to collection
Total patents: 12941
a) plating a single-cell suspension of hPSCs that are smaller than 50 μm at a seeding concentration of about 5×104 cells/cm2-about 1×105 cells/cm2 onto a suitable surface, and culturing the cells under conditions which prevent the hPSCs from aggregating and which induce differentiation of the hPSCs into vasculogenic progenitor cells;\n
b) harvesting the cultured cells of step a) and separating them into a single cell suspension of cells that are smaller than 50 μm;\n
c) plating the single cell suspension of step b) at a seeding concentration of about 1×104 cells/cm2-about 5×104 cells/cm2 on a suitable surface, and culturing the cells in a differentiation medium that is supplemented with platelet-derived growth factor BB (PDGF-BB) and transforming growth factor-beta 1 (TGF β1); and\n
d) stretching the cells from step c) by subjecting the cells to a flow-induced shear stress for a time period sufficient to enhance differentiation, maturation and/or functionality of the cells\n
wherein the human SMLCs are characterized by at least one of up regulated PDGFR-B, up regulated Calponin, up regulated SMA, up regulated Ang-1, and/or reduced expression of fibronectin, as compared to human aorta vascular smooth muscle cells."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the flow-induced shear stress applied to the cells from step c), is at least 1 dyne/cm2."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the flow-induced shear stress is exerted in a flow chamber."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the hPSCs are human embryonic stem cells (hESCs)."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the hPSCs are induced pluripotent stem cells (iPSCs)."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5, wherein the iPSCs are human iPSCs."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the SMLCs are human vascular SMLCs."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the method to generate single cell suspensions comprises trypsinizing the cells with TrypLE."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the single cell suspensions of cells that are smaller than 50 μm are generated by a method comprising sorting the cells through a 40-μm mesh strainer."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cells in step a) are plated at a seeding concentration of about 5×104."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the conditions in step a) that prevent the hPSCs from aggregating and induce differentiation of the hPSCs into vasculogenic progenitor cells comprise culturing the cells on an adhesive substrate, in a differentiation medium that comprises at least about 5% serum (v/v), for about 5 to 7 days."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 11, wherein the adhesive substrate is collagen-type-IV coated culture plate."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 11, wherein the differentiation medium comprises at least about 10% serum (v/v)."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cells in steps a) and c) are cultured as a monolayer."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cells in step c) are plated at a seeding concentration of less than about 2×104 cells/cm2."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cells in step c) are plated at a seeding concentration of about 1.25×104 cells/cm2."],"number":16,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein in step c), the concentration of PDGF-BB is about 5 ng/ml-about 50 ng/ml."],"number":17,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 17, wherein in step c), the concentration of PDGF-BB is about 5 ng/ml-about 10 ng/ml."],"number":18,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein in step c), the concentration of TGF-β is about 1 ng/ml-about 10 ng/ml."],"number":19,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 19, wherein the concentration of TGF-β is about 1 ng/ml."],"number":20,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cells generated in step c) are subjected to a stress of at least 1 dyne/cm2 for at least about 48 hours."],"number":21,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 21, wherein the stress is at least 5 dyne/cm2."],"number":22,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 21, wherein the stress is at least 10 dyne/cm2."],"number":23,"annotation":false,"claim":true,"title":false},{"lines":["A method for differentiating human embryonic stem cells (hESCs) into human smooth muscle-like cells (SMLCs) in vitro, comprising\n
a) plating a single-cell suspension of hESCs that have been filtered through a 40 μm strainer, to generate a population of cells that are smaller than 40 μm, at a seeding concentration of about 5×104 cells/cm2, onto a collagen IV coated plate, and culturing the cells in a differentiation medium that comprises about 10% serum, for about 6 days,\n
b) harvesting the cultured cells of step a) and filtering them through a 40 μm strainer to generate a single cell suspension of cells that are smaller than 40 μm;\n
c) plating the single cell suspension of step b) at a seeding concentration of less than about 2×104 cells/cm′ on a collagen IV coated plate, and culturing the cells in a differentiation medium comprising about 10% (v/v) of serum and that is supplemented with about 10 ng/ml of PDGF-BB and about 1 ng/ml of TGF β1, for about 6 days; and\n
d) stretching the cells from step c) by subjecting the cells to a flow-induced shear stress for at least 48 hours;\n
wherein the flow-induced shear stress is exerted in a flow chamber, and\n
wherein the human SMLCs are characterized by at least one of up regulated PDGFR-B, up regulated Calponin, up regulated SMA, up regulated Ang-1, and/or reduced expression of fibronectin, as compared to human aorta vascular smooth muscle cells."],"number":24,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 24, wherein the flow-induced shear stress is at least 10 dyne/cm2."],"number":25,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}